Cord Blood 25(oh)-Vitamin D Level in Preterm Infants and Associated Morbidities
NCT ID: NCT01812681
Last Updated: 2014-08-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
81 participants
OBSERVATIONAL
2012-10-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Levels in Neonatal Umbilical Cord Blood: Factors and Prognostic Analysis
NCT06111066
Comparison of Maternal and Neonatal Vitamin D Levels in Term Neonates With and Without Early Onset Sepsis
NCT02019836
Serum 25-hydroxy Vitamin D [25(OH)D] Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants
NCT01469650
Multi-dose Vitamin D Supplementation in Preterm Infants
NCT02941185
Maternal Vitamin D Status and Neonatal Bone Strength
NCT01630603
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low vitamin D level
The premature infants with low cord blood vitamin D level
No interventions assigned to this group
Normal Vitamin D
The premature infants with normal vitamin D level
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* infants \>32 weeks of gestational age
1 Day
5 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Sami Ulus Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Serdar Beken
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dilek Dilli, Assoc Prof
Role: STUDY_DIRECTOR
Sami Ulus CH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sami Ulus CH
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Grant WB. Vitamin D supplementation of mother and infant could reduce risk of sepsis in premature infants. Early Hum Dev. 2010 Feb;86(2):133. doi: 10.1016/j.earlhumdev.2010.02.003. Epub 2010 Feb 25. No abstract available.
Fettah ND, Zenciroglu A, Dilli D, Beken S, Okumus N. Is higher 25-hydroxyvitamin D level preventive for respiratory distress syndrome in preterm infants? Am J Perinatol. 2015 Feb;32(3):247-50. doi: 10.1055/s-0034-1383849. Epub 2014 Sep 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B.10.4.İSM.4.06.68.49
Identifier Type: OTHER
Identifier Source: secondary_id
B.10.4.İSM.4.06.68.49
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.